All Stories

  1. Circulating B Lymphocyte Subsets in Patients with Systemic Lupus Erythematosus
  2. Role of Plasma Angiopoietin-1 and VEGF Levels as Potential Biomarkers in Chronic Central Serous Chorioretinopathy with Macular Neovascularization
  3. Circulating Anti-Endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration
  4. Circulating Anti-endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration
  5. Updates in AERD: What is needed further?
  6. Comprehensive Analysis of Circular RNAs in Endothelial Cells
  7. Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients—Real-World Study
  8. Non‐eosinophilic asthma in nonsteroidal anti‐inflammatory drug exacerbated respiratory disease
  9. Sputum transcriptome analysis of co‐regulated genes related to arachidonic acid metabolism in N‐ERD
  10. SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis
  11. Profile of circulating extracellular vesicles microRNA correlates with the disease activity in granulomatosis with polyangiitis
  12. Intravenous administration of Tat-NR2B9c peptide, a PSD95 inhibitor, attenuates reinstatement of cocaine-seeking behavior in rats
  13. Dynamic in vitro hemocompatibility of oligoproline self-assembled monolayer surfaces
  14. MiR-191 as a Key Molecule in Aneurysmal Aortic Remodeling
  15. Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD
  16. The NMDA Receptor Subunit (GluN1 and GluN2A) Modulation Following Different Conditions of Cocaine Abstinence in Rat Brain Structures
  17. Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy
  18. Endothelial cells response to neutrophil‐derived extracellular vesicles miRNAs in anti‐PR3 positive vasculitis
  19. miRNA Regulation of NK Cells Antiviral Response in Children With Severe and/or Recurrent Herpes Simplex Virus Infections
  20. Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
  21. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study
  22. Design, Manufacturing Technology and In-Vitro Evaluation of Original, Polyurethane, Petal Valves for Application in Pulsating Ventricular Assist Devices
  23. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
  24. Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma
  25. Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy
  26. Emerging role of non-coding RNAs in allergic disorders
  27. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs
  28. The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans
  29. Association of Factor V Leiden With Subsequent Atherothrombotic Events
  30. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections
  31. Cocaine Self-Administration and Abstinence Modulate NMDA Receptor Subunits and Active Zone Proteins in the Rat Nucleus Accumbens
  32. Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy
  33. A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
  34. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium
  35. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection
  36. Legends of Allergy/Immunology: Andrew Szczeklik
  37. Artificial neural network identifies nonsteroidal anti‐inflammatory drugs exacerbated respiratory disease (N‐ERD) cohort
  38. The interaction of laser radiation with tissue in the aspect of generating the process of decellularization in the preparation of animal origin autologous tissue
  39. Subphenotypes of NSAID‐exacerbated respiratory disease identified by latent class analysis
  40. Reduced expression of miR-146a in human bronchial epithelial cells alters neutrophil migration
  41. LTB4 and 5-oxo-ETE from extracellular vesicles stimulate neutrophils in granulomatosis with polyangiitis
  42. IL-17–high asthma with features of a psoriasis immunophenotype
  43. Delayed neutrophil apoptosis in granulomatosis with polyangiitis: dysregulation of neutrophil gene signature and circulating apoptosis-related proteins
  44. Cocaine-induced Changes in the Expression of NMDA Receptor Subunits
  45. Subtypes of eosinophilic asthma with discrete gene pathway phenotypes
  46. A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience
  47. Stratification of asthma phenotypes by airway proteomic signatures
  48. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease
  49. Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux
  50. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events
  51. Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma
  52. Subsequent Event Risk in Individuals With Established Coronary Heart Disease
  53. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti‐inflammatory drug‐induced urticaria
  54. Stabilization of Synthetic Materials with Silver Particles
  55. Prostaglandin E2 decrease in induced sputum of hypersensitive asthmatics during oral challenge with aspirin
  56. Molecular profiling of regulatory T cells in pulmonary sarcoidosis
  57. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
  58. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper
  59. Facilitated expansion of Th17 cells in lupus nephritis patients
  60. Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort
  61. Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers
  62. U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes
  63. Eicosanoids and eosinophilic inflammation of airways in stable COPD.
  64. Topological data analysis (TDA) of U-BIOPRED paediatric peripheral blood gene expression identified asthma phenotypes characterised by alternative splicing of glucocorticoid receptor (GR) mRNA
  65. Correction to: Fibroblast-to-myofibroblast transition in bronchial asthma
  66. Surface modification of metallic materials designed for a new generation of artificial heart valves
  67. Fibroblast-to-myofibroblast transition in bronchial asthma
  68. Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome
  69. Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis
  70. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma
  71. Metamizole and Platelet Inhibition by Aspirin Following On-Pump Coronary Artery Bypass Grafting
  72. Influence of TNF-α promoter variability on stage and grade in individuals with colorectal cancer
  73. miR-200b downregulates CFTR during hypoxia in human lung epithelial cells
  74. Leukotrienes biosynthesis in coronary artery disease - results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) study
  75. Biomimetics in thin film design: Niche-like wrinkles designed for i-cell progenitor cell differentiation
  76. Respiratory syncytial virus infection influences tight junction integrity
  77. The effect of allergen-induced bronchoconstriction on concentration of 5-oxo-ETE in exhaled breath condensate of house dust mite-allergic patients
  78. Connective tissue growth factor regulates transition of primary bronchial fibroblasts to myofibroblasts in asthmatic subjects
  79. Volatile Organic Compounds Breathprinting of U-BIOPRED Severe Asthma smokers/ex-smokers cohort
  80. Urinary metabolomics-based molecular sub-phenotyping of the U-BIOPRED asthma cohort
  81. Connexin43 Controls the Myofibroblastic Differentiation of Bronchial Fibroblasts from Patients with Asthma
  82. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
  83. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331
  84. U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
  85. Cocaine Administration and Its Withdrawal Enhance the Expression of Genes Encoding Histone-Modifying Enzymes and Histone Acetylation in the Rat Prefrontal Cortex
  86. Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis
  87. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
  88. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients
  89. Urinary prostanoids in preschool wheeze
  90. Different forms of alpha-1 antitrypsin and neutrophil activation mediated by human anti-PR3 IgG antibodies
  91. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production
  92. Unbiased Profile of MicroRNA Expression in Ascending Aortic Aneurysm Tissue Appoints Molecular Pathways Contributing to the Pathology
  93. The genetic evidence for human origin of Jivaroan shrunken heads in collections from the Polish museums
  94. Effect of DHA/EPA supplementation on endothelial damage markers. The bioclaims study
  95. Urinary 11‐Dehydro‐Thromboxane B 2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
  96. Pentoxifylline and its active metabolite lisofylline attenuate transforming growth factor β1-induced asthmatic bronchial fibroblast-to-myofibroblast transition
  97. Wrinkle-like structures in reconstructing stem cell niches
  98. Serum anti-endothelial cell antibodies in patients with age-related macular degeneration treated with intravitreal bevacizumab
  99. Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease
  100. Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease
  101. Nanostructural haemocompatible coatings for the internal side of artificial blood vessels
  102. Silver nanoparticles influence on the blood activation process and their release to blood plasma from synthetic polymer scaffold
  103. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland
  104. Lesions in the wingless gene of the Apollo butterfly (Parnassius apollo, Lepidoptera: Papilionidae) individuals with deformed or reduced wings, coming from the isolated population in Pieniny (Poland)
  105. Prostaglandin E2in Induced Sputum Following Oralaspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity
  106. Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?
  107. Physicochemical and Biological Investigation of Different Structures of Carbon Coatings Deposited onto Polyurethane
  108. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease
  109. Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma
  110. CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier
  111. A lack of Wolbachia-specific DNA in samples from apollo butterfly (Parnassius apollo, Lepidoptera: Papilionidae) individuals with deformed or reduced wings
  112. Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways
  113. The first U-BIOPRED sputum handprint of severe asthma
  114. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics
  115. Mortality in end‑stage renal disease: the importance of the genetic background
  116. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug–related urticaria and angioedema
  117. Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia
  118. Neutrophil MiRNA-128-3p is Decreased During Active Phase of Granulomatosis with Polyangiitis
  119. T-cell regulation during viral and nonviral asthma exacerbations
  120. Circulating mitochondrial DNA in serum of patients with granulomatosis with polyangiitis
  121. In reply to the comment of Dr Asaf Achiron to a paper: Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration
  122. Computer engineering in designing and fabrication of tissue analogue-type coating dedicated for the cardiovascular regeneration
  123. Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells
  124. Erratum to: A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
  125. IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: Systematic review of its prevalence in chronic hepatitis C patients and general population frequency
  126. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients
  127. Unravelling adverse reactions to NSAIDs using systems biology
  128. Undifferentiated Bronchial Fibroblasts Derived from Asthmatic Patients Display Higher Elastic Modulus than Their Non-Asthmatic Counterparts
  129. Lack of association ofALOX12andALOX15Bpolymorphisms with psoriasis despite altered urinary excretion of 12(S)-hydroxyeicosatetraenoic acid
  130. S65 Urinary Prostaglandins As Inflammatory Markers For Childhood Asthma Exacerbations
  131. Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
  132. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study
  133. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity
  134. Graphene based porous coatings with antibacterial and antithrombogenous function—Materials and design
  135. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland
  136. Impact of Hymenoptera venom allergy and the effects of specific venom immunotherapy on mast cell metabolites in sensitized children
  137. AB0029 Imbalance between Immunoregulatory and Effector TH17 Pathway in Active Sle
  138. THU0498 Increase of CXCR3-CCR4+CCR6+CCR10- Memory T Helper Cells (TH17-LIKE) in Patients with Granulomatosis and Polyangiitis (GPA)
  139. Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration
  140. Th2-type cytokine induced mucous metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection
  141. Carbon in airway macrophages from children with asthma
  142. Risk factors for arterial thrombosis in antiphospholipid syndrome
  143. Phagocytosis of fossil fuel particulates by macrophages in children with asthma
  144. Eicosanoid biosynthesis during mucociliary and mucous metaplastic differentiation of bronchial epithelial cells
  145. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs
  146. Grubość kompleksu błona wewnętrzna – błona środkowa tętnicy szyjnej koreluje z cechami zespołu metabolicznego u osób młodych z kliniczną diagnozą rodzinnej hipercholesterolemii
  147. Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener’s) patients
  148. Genetics of Hypersensitivity to Aspirin and Nonsteroidal Anti-inflammatory Drugs
  149. Mutations of microsatellite autosomal loci in paternity investigations of the Southern Poland population
  150. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs
  151. Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener's) patients
  152. Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations
  153. Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4
  154. Transforming growth factor-β1‑induced expression of connective tissue growth factor is enhanced in bronchial fibroblasts derived from asthmatic patients
  155. Exhaled eicosanoid profiles in children with atopic asthma and healthy controls
  156. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients
  157. Prof. Andrzej Szczeklik, 1938–2012: aspirin-induced asthma and much more: Figure 1–
  158. Biographical memoir: Andrew Szczeklik 29 June 1938–3 February 2012
  159. CCR4-active chemokines contribute to blood and tissue eosinophilia in Churg–Strauss syndrome
  160. Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers
  161. The unfinished history of aspirin hypersensitivity – in memory of Professor Andrew Szczeklik
  162. 12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome
  163. Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens
  164. Nasal Inflammatory Mediators In Non-steroidal Anti-inflammatory Drugs (nsaids) Cross-intolerant Subjects After Lysine Nasal Challenge
  165. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus
  166. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C
  167. The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b
  168. A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
  169. Transition of asthmatic bronchial fibroblasts to myofibroblasts is inhibited by cell–cell contacts
  170. Circulating antiretinal antibodies predict the outcome of anti-VEGF therapy in patients with exudative age-related macular degeneration
  171. 832 INTIMA-MEDIA THICKNESS CORRELATES WITH FEATURES OF METABOLIC SYNDROME IN YOUNG PERSONS WITH CLINICAL DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA
  172. 592 MUTATION SPECTRUM IN THE LDL RECEPTOR GENE IN PATIENTS FROM THE SOUTH-EASTERN PART OF POLAND
  173. Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype
  174. Functional cardio-biomaterials
  175. Coxibs strike back
  176. Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation
  177. Eoxins: A new inflammatory pathway in childhood asthma
  178. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery
  179. Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects
  180. Glucocorticoid receptor isoforms in steroid‑dependent asthma
  181. MS424 THE EFFECT OF PAIN-FREE TREADMILL TRAINING ON LEVELS OF LACTATE DEHYDROGENASE AND CREATINE KINASE IN PATIENTS WITH INTERMITTENT CLAUDICATION
  182. Elevated urinary leukotriene E4excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA
  183. Functional promoter polymorphism of cyclooxygenase‑2 modulates the inflammatory response in stable coronary heart disease
  184. Assessment of hemocompatibility of materials with arterial blood flow by platelet functional tests
  185. Interaction of functionalFCER2promoter polymorphism and phenotype-associated haplotypes
  186. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg–Strauss syndrome
  187. Genetic associations of variants of the high affinity receptor for immunoglobulin E in Wegener’s granulomatosis
  188. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years
  189. Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease
  190. Single-stranded conformation polymorphism (SSCP)-driven indirect sequencing in detection of short deletion
  191. Genetic variability of the high-affinity IgE receptor α-subunit (FcεRIα)
  192. FCER1Agene proximal promoter polymorphisms in Caucasians and East Asians
  193. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma
  194. Aspirin tolerance and leukotriene biosynthesis in Churg-Strauss syndrome
  195. Two Different Transcription Factors Discriminate the −315C>T Polymorphism of the FcεRIα Gene: Binding of Sp1 to −315C and of a High Mobility Group-Related Molecule to −315T
  196. The Presence of Rhinovirus in Lower Airways of Patients with Bronchial Asthma
  197. FCER1A gene exon 1A polymorphisms in Japanese and Polish subjects – a comparative analysis of haplotypes
  198. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity
  199. The prevalence of alpha1-antitrypsin deficiency in a representative population sample from Poland
  200. Molecular diagnostics of α1-antitrypsin deficiency
  201. Coding region for the high affinity receptor of immunoglobulin E is highly conservative in allergic patients
  202. Additive association between FCER1A and FCER1B genetic polymorphisms and total serum IgE levels
  203. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin
  204. FCERIA gene promoter polymorphisms: Lack of association with aspirin hypersensitivity in whites
  205. GENETIC POLYMORPHISMS OF THE NOVEL FCER1A GENE REGION: RELATION TO TOTAL SERUM IgE LEVELS
  206. Rapid and Inexpensive Detection of α1-Antitrypsin Deficiency-Related Alleles S and Z by a Real-Time Polymerase Chain Reaction Suitable for a Large-Scale Population-Based Screening
  207. Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease
  208. Genetic Variability of the High-affinity IgE Receptor α Subunit (Fc ε RI α) is Related to Total Serum IgE levels in Allergic Subjects
  209. Hypersensitivity to Aspirin and Other NSAIDs: Mechanisms, Clinical Presentation and Management
  210. NOVEL EXON 2A OF THE HIGH-AFFINITY RECEPTOR FOR THE IgE α-CHAIN GENE (FCER1A) AND AUTOIMMUNITY IN PATIENTS WITH ASTHMA OR URTICARIA
  211. Towards a Multidisciplinary and Integrated Strategy in the Assessment of Adverse Health Effects Related to Air Pollution: The Case Study of Cracow (Poland) and Asthma
  212. Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria
  213. The α-chain of high-affinity receptor for IgE (FcɛRIα) gene polymorphisms and serum IgE levels
  214. Towards a multidisciplinary and integrated strategy in the assessment of adverse health effects related to air pollution: The case study of Cracow (Poland) and asthma
  215. Valine/Leucine247 polymorphism of β2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-β2-glycoprotein I antibodies
  216. The broken balance in aspirin hypersensitivity
  217. Familial aggregation of aspirin-induced urticaria and leukotriene C4 synthase allelic variant
  218. Rhinovirus Infection in Lower Airways of Asthmatic Patients
  219. Reactive Oxygen Species Metabolism and Allergy
  220. Anti-thrombotic action of clopidogrel and PlA1/A2polymorphism of β3 integrin in patients with coronary artery disease not being treated with aspirin
  221. Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism
  222. Aspirin resistance
  223. Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma
  224. Improved cardiac function in a patient with hypereosinophilic syndrome treated with imatinib
  225. The dopamine D4 receptor VNTR in Polish schizophrenia patients
  226. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients
  227. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma
  228. Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications
  229. Zinc treatment induces cortical brain-derived neurotrophic factor gene expression
  230. Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma
  231. Aspirin intolerance and the cyclooxygenase???leukotriene pathways
  232. X-Linked Alport Syndrome: Natural History and Genotype-Phenotype Correlations in Girls and Women Belonging to 195 Families: A "European Community Alport Syndrome Concerted Action" Study
  233. Aspirin and thrombinogenesis
  234. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma
  235. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis
  236. 3P-0859 The accuracy of D-dimer testing in patients with venous thromboembolism disease
  237. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist
  238. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease
  239. Repeated imipramine and electroconvulsive shock increase α1A-adrenoceptor mRNA level in rat prefrontal cortex
  240. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors
  241. Montelukast for persistent asthma
  242. Serum interleukin-5 in aspirin-induced asthma
  243. Leukotriene C4 synthase polymorphism and aspirin-induced asthma
  244. Aspirin-induced rhinitis and asthma
  245. Mutation A1298C of methylenetetrahydrofolate reductase: Risk for early coronary disease not associated with hyperhomocysteinemia
  246. A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma
  247. Genetics of aspirin induced asthma
  248. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa
  249. Enhanced Expression of the Leukotriene C4Synthase Due to Overactive Transcription of an Allelic Variant Associated with Aspirin-Intolerant Asthma
  250. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics
  251. X-linked Alport Syndrome
  252. Frequency data on the loci vWA, FES/FPS, F13A01, TH01, TPOX and CSF1P0 in a population from South Poland
  253. Genetic Mechanisms in Aspirin-induced Asthma
  254. Molecular Studies in Osteogenesis Imperfecta (OI)
  255. Biosynthesis of cysteinyl-leucotrienes in aspirin-intolerant asthma
  256. Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation
  257. Data on the loci LDLR, GYPA, HBGG, D7S8 and GC in a South Polish population
  258. Role of leukotrienes in aspirin-induced asthma
  259. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma
  260. D1S80 VNTR locus genotypes in population of South Poland; meta-analysis pointer to genetic disequilibrium of human populations
  261. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1
  262. Fine deletion mapping of the p22 region of the human X chromosome using a radiation-induced hybrid panel
  263. A gene for achondroplasia–hypochondroplasia maps to chromosome 4p
  264. Limnology Of Missouri Reservoirs: An Analysis of Regional Patterns
  265. Alport syndrome: a genetic study of 31 families
  266. Alport syndrome and diffuse leiomyomatosis: Deletions in the 5′ end of the COL4A5 collagen gene
  267. 165 MOLECULAR ANALYSIS OF PKU HAPLOTYPES IN THE POPULATION OF SOUTHERN POLAND
  268. 166 TIME-PLACE CLUSTERS ANALYSIS FOR SELECTED CONGENITAL MALFORMATION IN SOUTHERN POLAND
  269. Hypersensitivity to Aspirin and other NSAIDs